Weight-loss drug approved to reduce risk of non-fatal heart attacks | Canada Tonight

Written By Raven B

Health Canada has approved the weight-loss drug Wegovy to reduce the risk of non-fatal heart attacks, drug maker Novo Nordisk says. But how does it work? Dr. Samir Gupta discusses Health Canada's decision.

View the segment here.

Raven B
Next

Are You Drinking Enough Water? Here’s What Science Says